Trevena Announces Positive Results from Phase 2b Study of TRV130 in Acute Postoperative Pain Aug 31, 2015 4:01pm EDT
Trevena Reports Second Quarter 2015 Financial Results and Provides a Corporate Update Aug 11, 2015 7:00am EDT
Trevena Appoints Yacoub Habib as Senior Vice President, Business Development and Corporate Planning Jul 20, 2015 7:00am EDT
Trevena Announces Poster Presentation of Data for Delta Receptor Compound TRV250 at American Headache Society 57th Annual Scientific Meeting Jun 18, 2015 4:00pm EDT
Trevena Announces Presentation of Preclinical Data for Delta Receptor Compound TRV250 at International Headache Congress May 14, 2015 7:00am EDT
